Lopinavir and Ritonavir
- Manufacturer
- Mylan Laboratories Limited
- Effective date
- 2019-02-06
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 20:35:59
Label at a glance#
ProductLopinavir and Ritonavir
Active ingredientLOPINAVIR, RITONAVIR
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LOPINAVIR Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| RITONAVIR Pharmacologic Class Indexing | 7 | Indexing - Pharmacologic Class | 20230816 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1d2364f5-8b1e-7c9a-4518-7b359d95fa50 | Product name | 2 | 20250116 |
| 00d976a9-a12a-db3d-ac4e-27498af714cf | Product name | 5 | 20250115 |
| 7a5f5ac7-15c0-4d8b-bea4-b3b28cb83a8d | Product name | 1 | 20231023 |
| c8f34825-48cd-e7db-4048-c3be840a9308 | Product name | 5 | 20230123 |
| d1ee4fdb-1116-417b-8889-dc05571445b3 | Product name | 1 | 20160825 |
| f8d26468-b1dc-49d8-a188-8b5d531405ef | Product name | 1 | 20150731 |
| 0b1bb9d1-e628-4e7c-aada-fd6532257932 | Product name | 1 | 20150416 |
| 96979b26-bb9a-43d8-e3a6-d69b9e9f75e5 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 65015-299-50 | 2021-03-05 | C162847 | 48780-1 | ba0f9c33-5790-a910-e053-dadaa90a0b85 | 842106fb-8dd6-49d8-b32d-dd54f0610488 |
| 65015-299-50 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-5790-a910-e053-dadaa90a0b85 | 842106fb-8dd6-49d8-b32d-dd54f0610488 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65015-299-49 | Lopinavir and Ritonavir | 50 mg in 1 PACKET | GRANULE | 50 | 2 | |
| 65015-299-50 | Lopinavir and Ritonavir | 120 in 1 CARTON | GRANULE | 120 | 2 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Lopinavir and Ritonavir
- LOPINAVIR
- RITONAVIR
- ACESULFAME POTASSIUM
- SILICON DIOXIDE
- COPOVIDONE K25-31
- SORBITAN MONOLAURATE
- ETHYLCELLULOSE, UNSPECIFIED
- MANNITOL
- SODIUM STEARYL FUMARATE
- VANILLA
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 65015-299 | 65015-299-49, 65015-299-50 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LOPINAVIR | 2494G1JF75 | ACTIB |
| RITONAVIR | O3J8G9O825 | ACTIB |
| ACESULFAME POTASSIUM | 23OV73Q5G9 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| COPOVIDONE K25-31 | D9C330MD8B | IACT |
| SORBITAN MONOLAURATE | 6W9PS8B71J | IACT |
| ETHYLCELLULOSE, UNSPECIFIED | 7Z8S9VYZ4B | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| SODIUM STEARYL FUMARATE | 7CV7WJK4UI | IACT |
| VANILLA | Q74T35078H | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f7df8e64-bad0-434e-9d66-f69dc9dcaad5 | 842106fb-8dd6-49d8-b32d-dd54f0610488 | 2019-02-06 | f7df8e64-bad0-434e-9d66-f69dc9dcaad5 842106fb-8dd6-49d8-b32d-dd54f0610488 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
